Skip to main content
Veterinary Medicines

LINCOMICINA SP 400 mg/g, POLVO PARA ADMINISTRACIÓN EN AGUA DE BEBIDA

Authorised
  • Lincomycin hydrochloride

Product identification

Medicine name:
LINCOMICINA SP 400 mg/g, POLVO PARA ADMINISTRACIÓN EN AGUA DE BEBIDA
Active substance:
  • Lincomycin hydrochloride
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    400.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • S P Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • S P Veterinaria S.A.
  • Cenavisa S.L.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 1924 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."